Envy Products Join ShoutMD

Envy Medical has entered into an agreement with lifestyle healthcare company ALPHAEON to bring SilkPeel devices to physicians through ShoutMD, a social commerce site created exclusively for board certified specialists to share insights, collaborate with their peers, review the latest technologies and purchase products. Under the terms of the agreement, SilkPeel devices and accessories will be made available to all physician members with pricing, training and educational protocols by the end of October 2015.

ALPHAEON Appoints Presidents of the Americas and Asia Pacific

Jeff Castillo, MBA, has joined lifestyle healthcare company ALPHAEON as President of the Americas. Castillo was previously divisional vice president at Abbott Medical Optics (AMO) where he focused on customer needs and market dynamics. Prior to AMO, Castillo spent 22 years at Johnson & Johnson, where he held a variety of senior commercial positions based in the U.S. and Latin America.

ALPHAEON Acquires Clarion

ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings, has completed its acquisition of Clarion Medical Technologies for $55 million in a combination of cash and equity plus performance-based earnouts. Clarion, based in Canada, has more than 100 employees, 36 sales representatives and over 40 product licenses.

“We are excited to have Clarion join ALPHAEON,” said Robert E. Grant, CEO of ALPHAEON. “We view Clarion as a leading provider of lifestyle healthcare products in Canada and are thrilled to combine their products and experience with our platform.”

ALPHAEON Acquires TouchMD

ALPHAEON, a subsidiary of Strathspey Crown Holdings, has acquired TouchMD, a software platform that helps physicians educate patients. TouchMD is currently utilized in over 10 countries and more than 800 practices. APLPHAEON will be responsible for all operations, sales and promotions in the U.S. and international markets, effective immediately.

ALPHAEON Expands Partnership with TEOXANE Laboratories

ALPHAEON Corporation has expanded its partnership with Geneva-based TEOXANE Laboratories. Under terms of the agreement, TEOXANE will become the exclusive licensor and distributor of ALPHAEON’s neuromodulator, EVOSYAL, across the European Union, Central Europe, Russia and South Africa. The expanded partnership also provides TEOXANE with a right of first refusal to distribute all other ALPHAEON products and services that are brought to the European market.

ALPHAEON Acquires Licensing Rights To TouchMD

ALPHAEON Corporation, a lifestyle healthcare company and wholly-owned subsidiary of Strathspey Crown Holdings LLC, has acquired worldwide licensing rights to TouchMD (, an interactive software platform that helps specialty physicians educate patients before, during and after practice consultation. The software was designed to increase practice conversion rates and enhance the patient experience.